Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ImagecourtesyofPexelscropped.jpg

Image courtesy of Pexels 

Sustained and creative patient and public involvement and engagement (PPIE) is critical to the success of cancer vaccine trials and research.

The vaccine trials programme will rely on a wide range of engagement activities, with and for a variety of groups of people, to create opportunities for conversations and consultations on this fascinating and possibly game changing area of cancer research.

First steps: testing the water and preventative vaccinations

Consultations with patient groups began in the Spring and Summer of 2024. In partnership with Oxford’s Oncology Clinical Trials Office (OCTO), and with the help of professional facilitators, Oxford Cancer organised a pair of meetings to hear from people on the subject of cancer vaccinations. 

Read the full report.